PPARG and Alzheimer disease: In the Tg2576 animal model of AD, the cognitive ameliorations following activation of the peroxisome proliferator-activated receptor-gamma (PPARgamma) by rosiglitazone were associated with a restoration of firing frequency in dentate gyrus cells [76], suggesting that the firing activity could be a cellular marker of AD progression.